The FDA has approved Covid booster shots that target the omicron BA.5 subtype.
On January 5, 2022, in Brussels, Belgium, medical staff prepares a booster dosage of Pfizer’s coronavirus disease (COVID-19) vaccine. In anticipation of a new wave of infections this fall and …
The FDA has approved Covid booster shots that target the omicron BA.5 subtype. Read More